Johnson & Johnson $JNJ Stock Position Decreased by Safe Harbor Fiduciary LLC

Safe Harbor Fiduciary LLC cut its stake in shares of Johnson & Johnson (NYSE:JNJ) by 43.7% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,420 shares of the company’s stock after selling 2,657 shares during the period. Safe Harbor Fiduciary LLC’s holdings in Johnson & Johnson were worth $522,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. GFG Capital LLC purchased a new stake in Johnson & Johnson during the second quarter valued at about $35,000. Stone House Investment Management LLC acquired a new stake in shares of Johnson & Johnson during the first quarter valued at approximately $47,000. 1248 Management LLC purchased a new stake in shares of Johnson & Johnson in the 1st quarter valued at approximately $48,000. Harvest Fund Management Co. Ltd acquired a new position in Johnson & Johnson in the 1st quarter worth approximately $52,000. Finally, Pandora Wealth Inc. purchased a new position in Johnson & Johnson during the 1st quarter worth approximately $65,000. Institutional investors and hedge funds own 69.55% of the company’s stock.

Insider Transactions at Johnson & Johnson

In other Johnson & Johnson news, EVP Jennifer L. Taubert sold 56,471 shares of the stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $177.81, for a total transaction of $10,041,108.51. Following the transaction, the executive vice president directly owned 178,013 shares of the company’s stock, valued at $31,652,491.53. This represents a 24.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.16% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on JNJ shares. Wells Fargo & Company set a $212.00 target price on Johnson & Johnson and gave the company an “overweight” rating in a report on Friday, October 3rd. HSBC upped their price target on Johnson & Johnson from $210.00 to $215.00 and gave the company a “buy” rating in a research report on Thursday, October 16th. Guggenheim upgraded Johnson & Johnson from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $167.00 to $206.00 in a research report on Tuesday, September 23rd. Scotiabank began coverage on shares of Johnson & Johnson in a research report on Thursday, November 13th. They set a “sector outperform” rating and a $230.00 price objective on the stock. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Johnson & Johnson in a research note on Friday, October 31st. Four analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, Johnson & Johnson has an average rating of “Moderate Buy” and an average price target of $201.05.

Johnson & Johnson Stock Up 0.5%

Shares of Johnson & Johnson stock opened at $207.75 on Thursday. The firm has a market cap of $500.53 billion, a price-to-earnings ratio of 20.05, a P/E/G ratio of 2.19 and a beta of 0.38. The stock has a 50-day simple moving average of $190.05 and a 200-day simple moving average of $172.75. Johnson & Johnson has a 52-week low of $140.68 and a 52-week high of $207.81. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.07 and a quick ratio of 0.80.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings data on Wednesday, August 30th. The company reported $2.26 earnings per share for the quarter. The firm had revenue of $24.02 billion for the quarter. Johnson & Johnson had a net margin of 27.26% and a return on equity of 32.73%. On average, equities research analysts expect that Johnson & Johnson will post 10.58 earnings per share for the current fiscal year.

Johnson & Johnson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 25th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Tuesday, November 25th. Johnson & Johnson’s payout ratio is presently 50.19%.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.